Global GABA Receptor Agonist Drug Market By Product Type (Bamaluzole, Phenibut) And By End-Users/Application (Attention Deficit Hyperactivity Disorder (ADHD), Psychiatric Disorders and Depression) Global Market Share, Forecast Data, In-Depth Analysis, And Detailed Overview, and Forecast, 2013 - 2026

  • AMR-985159
  • April 2021
  • Pharmaceuticals
  • 142 Pages

Report Preview

The GABA Receptor Agonist Drug market research report provides an in-depth analysis of the currents trends, latest developments, scenario, market size, various drivers, restraints, and major players along with their profile details. Research report offers the historic data for year 2018 and 2019 and also provides the forecast data from year 2020 to 2028 which is based on revenue (USD Million). With the help of all these information research report helps the market participants to improve market positions. With the help of all these insights GABA Receptor Agonist Drug market research report recommends a business strategy for present market participants to strengthen their position in the market.

According to the report, the GABA Receptor Agonist Drug market size was USD xx million and it is expected to reach USD xx million by the end of 2028, with a CAGR of xx% during 2020-2028. While considering the volume shipments the global GABA Receptor Agonist Drug market stood at xx (Units/Tons) in 2020 and expected to cross near about xx (units/Tons) by the end of forecast period.

Furthermore, the research report includes the detailed information about major players and provides the data regarding the current market scenario as well as upcoming market opportunities or challenges. Similarly, in segment report covers the types, and applications according to the countries and key regions. The research report consists the various drivers and restraints for GABA Receptor Agonist Drug market along with their effects over the forecast period. Similarly, according to the region GABA Receptor Agonist Drug market research report includes the study of opportunities available in the market situation.

The GABA Receptor Agonist Drug market research report provides the in-depth data analysis by using the various graphs, figures, charts, and tables. Furthermore, the report provides the different business challenges which are impacting market growth in all direction.
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2019
Forecast Period Covered 2019 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Product Type Bamaluzole, Phenibut, Baclofen, Gaboxadol, Klonopin (clonazepam), Tiagbine
Applications Attention Deficit Hyperactivity Disorder (ADHD), Psychiatric Disorders and Depression, Alzheimer, Epilepsy and Seizure, Anxiety and Sleep Disorders, Obesity and Alcoholism
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Companies Covered Advicenne, AstraZeneca, Athena Drug Delivery Solutions, Biocodex, Elan Corporation, Eli Lilly and Company, H.LundBeck, Merck and Co, GlaxoSmithKline, NovaDel Pharma, Novartis, OVATION Pharmaceuticals, Osmotica Pharmaceutical, Pfizer, sanofi-aventis, VIVUS, XenoPort

Global GABA Receptor Agonist Drug Market Segmentation by Regions:
In regional analysis, GABA Receptor Agonist Drug market research report provides the detailed analysis from various regions and also contains the detailed analysis of country. Along with market revenue, market value report also offers the forecast analysis for the following countries and regions. Global GABA Receptor Agonist Drug market report covers the various geographical regions such as North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa. Also, various countries included are Canada, U.K., France, the U.S., Japan, China, India, and Germany and so on.

North America Region for GABA Receptor Agonist Drug Market: Value and Forecast
  • U.S.
  • Canada
 
Europe Region for GABA Receptor Agonist Drug Market: Value and Forecast
  • UK
  • Germany
  • France
  • Rest of the Europe
 
Asia Pacific Region for GABA Receptor Agonist Drug Market: Value and Forecast
  • China
  • Japan
  • India
  • Rest of the Asia Pacific
 
Latin America Region for GABA Receptor Agonist Drug Market: Value and Forecast
  • Mexico
  • Brazil
  • Rest of the Latin America
 
Middle East and Africa for GABA Receptor Agonist Drug Market: Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa



Global GABA Receptor Agonist Drug Market Segmentation by Type:
On the basis of product type, global GABA Receptor Agonist Drug market research report provides the production, revenue, price, and market share and growth rate of each type, primarily split into: Bamaluzole, Phenibut, Baclofen, Gaboxadol, Klonopin (clonazepam), Tiagbine

Global GABA Receptor Agonist Drug Market Segmentation by Applications:
On the basis of the end users/applications, GABA Receptor Agonist Drug research report analyze the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including: Attention Deficit Hyperactivity Disorder (ADHD), Psychiatric Disorders and Depression, Alzheimer, Epilepsy and Seizure, Anxiety and Sleep Disorders, Obesity and Alcoholism

Major Key Players for Global GABA Receptor Agonist Drug Market:
The GABA Receptor Agonist Drug market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Advicenne, AstraZeneca, Athena Drug Delivery Solutions, Biocodex, Elan Corporation, Eli Lilly and Company, H.LundBeck, Merck and Co, GlaxoSmithKline, NovaDel Pharma, Novartis, OVATION Pharmaceuticals, Osmotica Pharmaceutical, Pfizer, sanofi-aventis, VIVUS, XenoPort

Important Points Covered by Report:
  • To analyze the value of the GABA Receptor Agonist Drug market, according to the key region.
  • To study the GABA Receptor Agonist Drug market current trends, prospects and also their participation in the entire sector.
  • Report consists the in-depth information related to the region/countries, major key players, current trends and their analysis, product type, applications, and other background information
  • Report provides the detailed information about drivers, restraints and future scope of GABA Receptor Agonist Drug market.
  • Report covers the information about historic data analysis as well as forecast period analysis.

Global GABA Receptor Agonist Drug research report consist the information about overall sales and revenue during the historic and forecasted period of 2018 to 2028. Additionally, this report covers the inside and out factual examination and the market elements and requests which give an entire situation of the business.

Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the GABA Receptor Agonist Drug market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the GABA Receptor Agonist Drug market for numerous purposes such as:

    1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the GABA Receptor Agonist Drug market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the GABA Receptor Agonist Drug market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the GABA Receptor Agonist Drug market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Advicenne
  • AstraZeneca
  • Athena Drug Delivery Solutions
  • Biocodex
  • Elan Corporation
  • Eli Lilly and Company
  • H.LundBeck, Merck and Co
  • GlaxoSmithKline
  • NovaDel Pharma
  • Novartis
  • OVATION Pharmaceuticals
  • Osmotica Pharmaceutical
  • Pfizer
  • sanofi-aventis
  • VIVUS
  • XenoPort
  • Bamaluzole
  • Phenibut
  • Baclofen
  • Gaboxadol
  • Klonopin (clonazepam)
  • Tiagbine
  • Attention Deficit Hyperactivity Disorder (ADHD)
  • Psychiatric Disorders and Depression
  • Alzheimer
  • Epilepsy and Seizure
  • Anxiety and Sleep Disorders
  • Obesity and Alcoholism

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summary
     2.1. Global GABA Receptor Agonist Drug Market Snapshot
          2.1.1. Global GABA Receptor Agonist Drug Market By Type,2019
               2.1.1.1.Bamaluzole
               2.1.1.2.Phenibut
               2.1.1.3.Baclofen
               2.1.1.4.Gaboxadol
               2.1.1.5.Klonopin (clonazepam)
               2.1.1.6.Tiagbine
          2.1.2. Global GABA Receptor Agonist Drug Market By Application,2019
               2.1.2.1.Attention Deficit Hyperactivity Disorder (ADHD)
               2.1.2.2.Psychiatric Disorders and Depression
               2.1.2.3.Alzheimer
               2.1.2.4.Epilepsy and Seizure
               2.1.2.5.Anxiety and Sleep Disorders
               2.1.2.6.Obesity and Alcoholism
          2.1.3. Global GABA Receptor Agonist Drug Market By End-use,2019
          2.1.4. Global GABA Receptor Agonist Drug Market By Geography,2019

3. Global GABA Receptor Agonist Drug Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global GABA Receptor Agonist Drug Market Size (US$), By Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Type, 2020
     4.2. Global GABA Receptor Agonist Drug Market Size (US$), By Type, 2018 – 2028

5. Global GABA Receptor Agonist Drug Market Size (US$), By Application, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Application, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Application, 2020
     5.2. Global GABA Receptor Agonist Drug Market Size (US$), By Application, 2018 – 2028

6. Global GABA Receptor Agonist Drug Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global GABA Receptor Agonist Drug Market Size (US$), By End-use, 2018 – 2028

7. Global GABA Receptor Agonist Drug Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America GABA Receptor Agonist Drug Market Analysis, 2018 – 2028 
          7.2.1. North America GABA Receptor Agonist Drug Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America GABA Receptor Agonist Drug Market Size (US$), By Type, 2018 – 2028
          7.2.3. North America GABA Receptor Agonist Drug Market Size (US$), By Application, 2018 – 2028
          7.2.4. North America GABA Receptor Agonist Drug Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe GABA Receptor Agonist Drug Market Analysis, 2018 – 2028 
          7.3.1.  Europe GABA Receptor Agonist Drug Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe GABA Receptor Agonist Drug Market Size (US$), By Type, 2018 – 2028
          7.3.3. Europe GABA Receptor Agonist Drug Market Size (US$), By Application, 2018 – 2028
          7.3.4. Europe GABA Receptor Agonist Drug Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific GABA Receptor Agonist Drug Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific GABA Receptor Agonist Drug Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific GABA Receptor Agonist Drug Market Size (US$), By Type, 2018 – 2028
          7.4.3. Asia Pacific GABA Receptor Agonist Drug Market Size (US$), By Application, 2018 – 2028
          7.4.4. Asia Pacific GABA Receptor Agonist Drug Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America GABA Receptor Agonist Drug Market Analysis, 2018 – 2028 
          7.5.1.  Latin America GABA Receptor Agonist Drug Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America GABA Receptor Agonist Drug Market Size (US$), By Type, 2018 – 2028
          7.5.3. Latin America GABA Receptor Agonist Drug Market Size (US$), By Application, 2018 – 2028
          7.5.4. Latin America GABA Receptor Agonist Drug Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) GABA Receptor Agonist Drug Market Analysis, 2018 – 2028 
          7.6.1.  MEA GABA Receptor Agonist Drug Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA GABA Receptor Agonist Drug Market Size (US$), By Type, 2018 – 2028
          7.6.3. MEA GABA Receptor Agonist Drug Market Size (US$), By Application, 2018 – 2028
          7.6.4. MEA GABA Receptor Agonist Drug Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key GABA Receptor Agonist Drug Providers
        8.4.1 Advicenne
                8.1.1 Business Description
                8.1.2 Advicenne Geographic Operations
                8.1.3 Advicenne Financial Information
                8.1.4 Advicenne Product Positions/Portfolio
                8.1.5 Advicenne Key Developments
        8.4.2 AstraZeneca
                8.2.1 Business Description
                8.2.2 AstraZeneca Geographic Operations
                8.2.3 AstraZeneca Financial Information
                8.2.4 AstraZeneca Product Positions/Portfolio
                8.2.5 AstraZeneca Key Developments
        8.4.3 Athena Drug Delivery Solutions
                8.3.1 Business Description
                8.3.2 Athena Drug Delivery Solutions Geographic Operations
                8.3.3 Athena Drug Delivery Solutions Financial Information
                8.3.4 Athena Drug Delivery Solutions Product Positions/Portfolio
                8.3.5 Athena Drug Delivery Solutions Key Developments
        8.4.4 Biocodex
                8.4.1 Business Description
                8.4.2 Biocodex Geographic Operations
                8.4.3 Biocodex Financial Information
                8.4.4 Biocodex Product Positions/Portfolio
                8.4.5 Biocodex Key Developments
        8.4.5 Elan Corporation
                8.5.1 Business Description
                8.5.2 Elan Corporation Geographic Operations
                8.5.3 Elan Corporation Financial Information
                8.5.4 Elan Corporation Product Positions/Portfolio
                8.5.5 Elan Corporation Key Developments
        8.4.6 Eli Lilly and Company
                8.6.1 Business Description
                8.6.2 Eli Lilly and Company Geographic Operations
                8.6.3 Eli Lilly and Company Financial Information
                8.6.4 Eli Lilly and Company Product Positions/Portfolio
                8.6.5 Eli Lilly and Company Key Developments
        8.4.7 H.LundBeck, Merck and Co
                8.7.1 Business Description
                8.7.2 H.LundBeck, Merck and Co Geographic Operations
                8.7.3 H.LundBeck, Merck and Co Financial Information
                8.7.4 H.LundBeck, Merck and Co Product Positions/Portfolio
                8.7.5 H.LundBeck, Merck and Co Key Developments
        8.4.8 GlaxoSmithKline
                8.8.1 Business Description
                8.8.2 GlaxoSmithKline Geographic Operations
                8.8.3 GlaxoSmithKline Financial Information
                8.8.4 GlaxoSmithKline Product Positions/Portfolio
                8.8.5 GlaxoSmithKline Key Developments
        8.4.9 NovaDel Pharma
                8.9.1 Business Description
                8.9.2 NovaDel Pharma Geographic Operations
                8.9.3 NovaDel Pharma Financial Information
                8.9.4 NovaDel Pharma Product Positions/Portfolio
                8.9.5 NovaDel Pharma Key Developments
        8.4.10 Novartis
                8.10.1 Business Description
                8.10.2 Novartis Geographic Operations
                8.10.3 Novartis Financial Information
                8.10.4 Novartis Product Positions/Portfolio
                8.10.5 Novartis Key Developments
        8.4.11 OVATION Pharmaceuticals
                8.11.1 Business Description
                8.11.2 OVATION Pharmaceuticals Geographic Operations
                8.11.3 OVATION Pharmaceuticals Financial Information
                8.11.4 OVATION Pharmaceuticals Product Positions/Portfolio
                8.11.5 OVATION Pharmaceuticals Key Developments
        8.4.12 Osmotica Pharmaceutical
                8.12.1 Business Description
                8.12.2 Osmotica Pharmaceutical Geographic Operations
                8.12.3 Osmotica Pharmaceutical Financial Information
                8.12.4 Osmotica Pharmaceutical Product Positions/Portfolio
                8.12.5 Osmotica Pharmaceutical Key Developments
        8.4.13 Pfizer
                8.13.1 Business Description
                8.13.2 Pfizer Geographic Operations
                8.13.3 Pfizer Financial Information
                8.13.4 Pfizer Product Positions/Portfolio
                8.13.5 Pfizer Key Developments
        8.4.14 sanofi-aventis
                8.14.1 Business Description
                8.14.2 sanofi-aventis Geographic Operations
                8.14.3 sanofi-aventis Financial Information
                8.14.4 sanofi-aventis Product Positions/Portfolio
                8.14.5 sanofi-aventis Key Developments
        8.4.15 VIVUS
                8.15.1 Business Description
                8.15.2 VIVUS Geographic Operations
                8.15.3 VIVUS Financial Information
                8.15.4 VIVUS Product Positions/Portfolio
                8.15.5 VIVUS Key Developments
        8.4.16 XenoPort
                8.16.1 Business Description
                8.16.2 XenoPort Geographic Operations
                8.16.3 XenoPort Financial Information
                8.16.4 XenoPort Product Positions/Portfolio
                8.16.5 XenoPort Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global GABA Receptor Agonist Drug Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America GABA Receptor Agonist Drug Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America GABA Receptor Agonist Drug Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 6 North America GABA Receptor Agonist Drug Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe GABA Receptor Agonist Drug Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe GABA Receptor Agonist Drug Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe GABA Receptor Agonist Drug Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific GABA Receptor Agonist Drug Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific GABA Receptor Agonist Drug Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific GABA Receptor Agonist Drug Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America GABA Receptor Agonist Drug Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America GABA Receptor Agonist Drug Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America GABA Receptor Agonist Drug Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA GABA Receptor Agonist Drug Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA GABA Receptor Agonist Drug Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA GABA Receptor Agonist Drug Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global GABA Receptor Agonist Drug: Market Segmentation 
FIG. 2 Global GABA Receptor Agonist Drug Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global GABA Receptor Agonist Drug Market, By Type, 2019 (US$ Mn) 
FIG. 5 Global GABA Receptor Agonist Drug Market, By Application, 2019 (US$ Mn) 
FIG. 6 Global GABA Receptor Agonist Drug Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global GABA Receptor Agonist Drug Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global GABA Receptor Agonist Drug Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key GABA Receptor Agonist Drug Providers, 2019
FIG. 11 Global GABA Receptor Agonist Drug Market Revenue Contribution, By Type, 2019 & 2028 (Value %) 
FIG. 12 Global GABA Receptor Agonist Drug Market Revenue Contribution, By Application, 2019 & 2028 (Value %) 
FIG. 13 Global GABA Receptor Agonist Drug Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America GABA Receptor Agonist Drug Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe GABA Receptor Agonist Drug Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific GABA Receptor Agonist Drug Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America GABA Receptor Agonist Drug Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA GABA Receptor Agonist Drug Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the GABA Receptor Agonist Drug market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global GABA Receptor Agonist Drug Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America GABA Receptor Agonist Drug Market Value, By Segment1, 2018 – 2028
TABLE  North America GABA Receptor Agonist Drug Market Value, By Segment2, 2018 – 2028
TABLE  North America GABA Receptor Agonist Drug Market Value, By Country, 2018 – 2028
TABLE  Europe GABA Receptor Agonist Drug Market Value, By Segment1, 2018 – 2028
TABLE  Europe GABA Receptor Agonist Drug Market Value, By Segment2, 2018 – 2028
TABLE  Europe GABA Receptor Agonist Drug Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific GABA Receptor Agonist Drug Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific GABA Receptor Agonist Drug Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific GABA Receptor Agonist Drug Market Value, By Country, 2018 – 2028
TABLE  Latin America GABA Receptor Agonist Drug Market Value, By Segment1, 2018 – 2028
TABLE  Latin America GABA Receptor Agonist Drug Market Value, By Segment2, 2018 – 2028
TABLE  Latin America GABA Receptor Agonist Drug Market Value, By Country, 2018 – 2028
TABLE  MEA GABA Receptor Agonist Drug Market Value, By Segment1, 2018 – 2028
TABLE  MEA GABA Receptor Agonist Drug Market Value, By Segment2, 2018 – 2028
TABLE  MEA GABA Receptor Agonist Drug Market Value, By Country, 2018 – 2028
TABLE  Advicenne: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  AstraZeneca: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Athena Drug Delivery Solutions: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Biocodex: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Elan Corporation: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Eli Lilly and Company: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  H.LundBeck, Merck and Co: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  GlaxoSmithKline: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  NovaDel Pharma: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Novartis: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  OVATION Pharmaceuticals: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Osmotica Pharmaceutical: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Pfizer: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  sanofi-aventis: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  VIVUS: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  XenoPort: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global GABA Receptor Agonist Drug Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global GABA Receptor Agonist Drug Market, By Segment1, 2019 (US$ Mn)
FIG.  Global GABA Receptor Agonist Drug Market, By Segment2, 2019 (US$ Mn)
FIG.  Global GABA Receptor Agonist Drug Market, By Geography, 2019 (US$ Mn)
FIG.  Global GABA Receptor Agonist Drug Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key GABA Receptor Agonist Drug Providers, 2016
FIG.  Global GABA Receptor Agonist Drug Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Bamaluzole Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Phenibut Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Baclofen Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Gaboxadol Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Klonopin (clonazepam) Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Tiagbine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global GABA Receptor Agonist Drug Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Attention Deficit Hyperactivity Disorder (ADHD) Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Psychiatric Disorders and Depression Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Alzheimer Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Epilepsy and Seizure Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Anxiety and Sleep Disorders Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Obesity and Alcoholism Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. GABA Receptor Agonist Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada GABA Receptor Agonist Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK GABA Receptor Agonist Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany GABA Receptor Agonist Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  France GABA Receptor Agonist Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe GABA Receptor Agonist Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  China GABA Receptor Agonist Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan GABA Receptor Agonist Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  India GABA Receptor Agonist Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific GABA Receptor Agonist Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico GABA Receptor Agonist Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil GABA Receptor Agonist Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America GABA Receptor Agonist Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries GABA Receptor Agonist Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa GABA Receptor Agonist Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA GABA Receptor Agonist Drug Market Value, 2018 – 2028, (US$ Mn)